| LONZA N | 340.50 / +1.10% |
| Date/Time | 12/06 / 17:30 |
| Chg. / Chg.(%) | 3.70 / +1.10% |
| Bid | 338.10 / 100 |
| Ask | 341.70 / 100 |
| Open | 337.80 |
| Previous Close | 336.80 |
| High | 341.30 |
| Low | 336.60 |
| Volume [CHF] | 72,583,804.70 |
| Volume [Units] | 228,474 |
| Price fixings | 4690 |
| ISIN | CH0013841017 |
| Security | LONN |
| Exchange | SIX Swiss Exchange |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 307.700 |  |
|
| SIX Swiss Ex.. | 340.50 |  |
228,474 |
| London Inter.. | 339.56 | |
9,919 |
| Nasdaq Other.. | 341.5081 | 15 | |
| Cboe Europe .. | 328.30 | 47,868 | |
| Turquoise | 328.30 | |
18,782 |
| Cboe Europe .. | 328.00 | 12,923 | |
| TradeGate | 294.000 | 298 | |
| Stuttgart | 294.000 | 135 | |
| Frankfurt | 293.9000 | 63 | |
| Düsseldorf | 291.20 | 0 | |
| München | 291.30 | 0 | |
| Berlin | 296.90 | 0 | |
| Hamburg | 291.30 | 0 | |
| gettex | 296.100 | ||
| Singapore | 79.97 | 500 | |
| EUREX | Options | ||
News
- Amarantus Subsidiary Elto Pharma Receives Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson’s Disease
12/04/2019 / 13:36 - GlobeNewswire - Amarantus Announces Issuance of Chinese Patent Covering the Use of MANF and CDNF in Retinal Disorders for Subsidiary MANF Therapeutics
11/21/2019 / 14:00 - GlobeNewswire - Rentschler Biopharma Appoints New Executives to Join U.S. Team
11/18/2019 / 16:00 - GlobeNewswire - Amarantus Provides Recapitalization Update to Shareholders
11/18/2019 / 14:30 - GlobeNewswire - Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test Relationship with Amyloid PET
11/14/2019 / 17:02 - GlobeNewswire
Real-time